TY  - RPRT
TI  - Do innovative medicines against cancer always have a real added value?
AU  - Neyt Mattias
AU  - Devos Carl
AU  - Thiry Nancy
AU  - Silversmit Geert
AU  - De Gendt Cindy
AU  - Van Damme Nancy
AU  - Castanares-Zapatero Diego
AU  - Fairon Nicolas
AU  - Hulstaert Frank
AU  - Verleye Leen
AB  - KCE Reports 343C (2021)

During the past twenty years, a number of cancer treatments considered innovative have been introduced, such as monoclonal antibodies and immunotherapies. But what exactly should we expect from a new cancer treatment? That it prolongs life and/or that it improves quality of life.
T2  - KCE Reports
CY  - Brussels
PY  - 2021
LA  - English
M3  - Health Technology Assessment (HTA)
PB  - Belgian Health Care Knowledge Centre (KCE)
SN  - 343
VO  - D/2021/10.273/22
DO  - https://doi.org/10.57598/R343C
ER -